These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 27590518)

  • 1. Clues toward precision medicine in oral squamous cell carcinoma: utility of next-generation sequencing for the prognostic stratification of high-risk patients harboring neck lymph node extracapsular extension.
    Wang HM; Liao CT; Yen TC; Chen SJ; Lee LY; Hsieh CH; Lin CY; Ng SH
    Oncotarget; 2016 Sep; 7(39):63082-63092. PubMed ID: 27590518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-deep targeted sequencing of advanced oral squamous cell carcinoma identifies a mutation-based prognostic gene signature.
    Chen SJ; Liu H; Liao CT; Huang PJ; Huang Y; Hsu A; Tang P; Chang YS; Chen HC; Yen TC
    Oncotarget; 2015 Jul; 6(20):18066-80. PubMed ID: 25980437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Ultra-Deep Targeted Sequencing Gene Panel Improves the Prognostic Stratification of Patients With Advanced Oral Cavity Squamous Cell Carcinoma.
    Liao CT; Chen SJ; Lee LY; Hsueh C; Yang LY; Lin CY; Fan KH; Wang HM; Ng SH; Lin CH; Tsao CK; Chen IH; Chang KP; Huang SF; Kang CJ; Chen HC; Yen TC
    Medicine (Baltimore); 2016 Feb; 95(8):e2751. PubMed ID: 26937903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Missense mutations in the TP53 DNA-binding domain predict outcomes in patients with advanced oral cavity squamous cell carcinoma.
    Lapke N; Lu YJ; Liao CT; Lee LY; Lin CY; Wang HM; Ng SH; Chen SJ; Yen TC
    Oncotarget; 2016 Jul; 7(28):44194-44210. PubMed ID: 27283772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant GDF15 presents a poor prognostic outcome for patients with oral squamous cell carcinoma.
    Ma J; Tang X; Sun WW; Liu Y; Tan YR; Ma HL; Zhu DW; Wang M; Wang LZ; Li J; Tu YY; Zhang CP; Zhang ZY; Zhong LP
    Oncotarget; 2016 Jan; 7(2):2113-22. PubMed ID: 26544895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter Retrospective Study of Adjuvant Therapy for Patients with Pathologically Lymph Node-Positive Oral Squamous Cell Carcinoma: Analysis of Covariance Using Propensity Score.
    Yanamoto S; Otsuru M; Ota Y; Okura M; Aikawa T; Kurita H; Kamata T; Kirita T; Yamakawa N; Ueda M; Yamashita T; Komori T; Shigeta T; Yokoo S; Ogawa M; Umeda M;
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S992-9. PubMed ID: 26289809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted next-generation sequencing of 50 cancer-related genes in Japanese patients with oral squamous cell carcinoma.
    Nakagaki T; Tamura M; Kobashi K; Omori A; Koyama R; Idogawa M; Ogi K; Hiratsuka H; Tokino T; Sasaki Y
    Tumour Biol; 2018 Sep; 40(9):1010428318800180. PubMed ID: 30226113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beyond Positive Margins and Extracapsular Extension: Evaluating the Utilization and Clinical Impact of Postoperative Chemoradiotherapy in Resected Locally Advanced Head and Neck Cancer.
    Trifiletti DM; Smith A; Mitra N; Grover S; Lukens JN; Cohen RB; Read P; Mendenhall WM; Lin A; Swisher-McClure S
    J Clin Oncol; 2017 May; 35(14):1550-1560. PubMed ID: 28475848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of patients with oral cavity squamous cell carcinoma and retropharyngeal lymph node metastasis identified by FDG PET/CT.
    Tseng JR; Ho TY; Lin CY; Lee LY; Wang HM; Liao CT; Yen TC
    PLoS One; 2013; 8(11):e79766. PubMed ID: 24244559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extent of pathologic extracapsular extension and outcomes in patients with nonoropharyngeal head and neck cancer treated with initial surgical resection.
    Prabhu RS; Hanasoge S; Magliocca KR; Moeller BJ; Milas ZL; Hall WA; El-Deiry M; Wadsworth JT; Higgins KA; Beitler JJ
    Cancer; 2014 May; 120(10):1499-506. PubMed ID: 24510454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck dissection field and lymph node density predict prognosis in patients with oral cavity cancer and pathological node metastases treated with adjuvant therapy.
    Liao CT; Hsueh C; Lee LY; Lin CY; Fan KH; Wang HM; Huang SF; Chen IH; Kang CJ; Ng SH; Tsao CK; Huang YC; Yen TC
    Oral Oncol; 2012 Apr; 48(4):329-36. PubMed ID: 22104249
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the level of progression of extracapsular spread for cervical lymph node metastasis in oral squamous cell carcinoma.
    Yamada S; Yanamoto S; Otani S; Hasegawa T; Miyakoshi M; Minamikawa T; Ohga N; Kamata T; Komori T; Kitagawa Y; Kurita H; Umeda M
    Int J Oral Maxillofac Surg; 2016 Feb; 45(2):141-6. PubMed ID: 26439759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA methylation analysis by bisulfite next-generation sequencing for early detection of oral squamous cell carcinoma and high-grade squamous intraepithelial lesion from oral brushing.
    Morandi L; Gissi D; Tarsitano A; Asioli S; Monti V; Del Corso G; Marchetti C; Montebugnoli L; Foschini MP
    J Craniomaxillofac Surg; 2015 Oct; 43(8):1494-500. PubMed ID: 26302938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Positive clinical impact of an additional PET/CT scan before adjuvant radiotherapy or concurrent chemoradiotherapy in patients with advanced oral cavity squamous cell carcinoma.
    Kang CJ; Lin CY; Yang LY; Ho TY; Lee LY; Fan KH; Wang HM; Huang SF; Chang KP; Fang KH; Ng SH; Liao CT; Yen TC
    J Nucl Med; 2015 Jan; 56(1):22-30. PubMed ID: 25525186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative [18F]fluorodeoxyglucose positron emission tomography standardized uptake value of neck lymph nodes predicts neck cancer control and survival rates in patients with oral cavity squamous cell carcinoma and pathologically positive lymph nodes.
    Liao CT; Chang JT; Wang HM; Ng SH; Hsueh C; Lee LY; Lin CH; Chen IH; Huang SF; Cheng AJ; Yen TC
    Int J Radiat Oncol Biol Phys; 2009 Jul; 74(4):1054-61. PubMed ID: 19101096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted next-generation sequencing identifies molecular subgroups in squamous cell carcinoma of the head and neck with distinct outcome after concurrent chemoradiation.
    Tinhofer I; Stenzinger A; Eder T; Konschak R; Niehr F; Endris V; Distel L; Hautmann MG; Mandic R; Stromberger C; Weichert W; Budach V
    Ann Oncol; 2016 Dec; 27(12):2262-2268. PubMed ID: 27681865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total lesion glycolysis: a possible new prognostic parameter in oral cavity squamous cell carcinoma.
    Abd El-Hafez YG; Moustafa HM; Khalil HF; Liao CT; Yen TC
    Oral Oncol; 2013 Mar; 49(3):261-8. PubMed ID: 23036774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node density is a significant predictor of outcome in patients with oral cancer.
    Gil Z; Carlson DL; Boyle JO; Kraus DH; Shah JP; Shaha AR; Singh B; Wong RJ; Patel SG
    Cancer; 2009 Dec; 115(24):5700-10. PubMed ID: 19691095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutational spectrum of tobacco associated oral squamous carcinoma and its therapeutic significance.
    Batta N; Pandey M
    World J Surg Oncol; 2019 Nov; 17(1):198. PubMed ID: 31775759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.